About CRH Medical (NYSEAMERICAN:CRHM)
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology. The Company's product distribution strategy focuses on physician education, patient outcomes, and patient awareness. The Company's CRH O'Regan System, platform that provides gastrointestinal is a single use, disposable, hemorrhoid banding technology for treating hemorrhoid grades I-IV. The Company distributes the CRH O'Regan System, treatment protocols, operational and marketing expertise as a package to physicians. The Company's subsidiary, Gastroenterology Anesthesia Associates, LLC, provides anesthesiology services for gastroenterology procedures.
Industry, Sector and Symbol:
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: N/A
- Sector: N/A
- Symbol: NYSEAMERICAN:CRHM
- Previous Symbol: NYSEARCA:CRHM
- CUSIP: N/A
- Web: investors.crhsystem.com
- Outstanding Shares: 74,130,000
Frequently Asked Questions for CRH Medical (NYSEAMERICAN:CRHM)
What is CRH Medical's stock symbol?
CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."
How were CRH Medical's earnings last quarter?
CRH Medical Co. (NYSEAMERICAN:CRHM) released its quarterly earnings results on Wednesday, February, 22nd. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.01. The firm had revenue of $25.82 million for the quarter, compared to the consensus estimate of $23.30 million. View CRH Medical's Earnings History.
When will CRH Medical make its next earnings announcement?
Where is CRH Medical's stock going? Where will CRH Medical's stock price be in 2017?
9 analysts have issued 12-month price objectives for CRH Medical's stock. Their predictions range from $5.00 to $10.00. On average, they expect CRH Medical's share price to reach $7.83 in the next twelve months. View Analyst Ratings for CRH Medical.
What are Wall Street analysts saying about CRH Medical stock?
Here are some recent quotes from research analysts about CRH Medical stock:
- 1. According to Zacks Investment Research, "CRH Medical Corporation offers products and services to physicians for the treatment of gastrointestinal diseases primarily in the United States. The company provides the CRH O'Regan System, a single use, disposable and hemorrhoid banding technology for treating hemorrhoid grades I - IV. It distributes the CRH O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to physicians. The company utilizes Web-based platform to connect doctors with patients as well as educating its install base of physicians. It also offers anesthesia services. CRH Medical Corporation is headquartered in Vancouver, Canada. " (11/14/2017)
- 2. Cantor Fitzgerald analysts commented, "We are boosting our price target to $10 from $8 and reiterating our Overweight rating as we become more confident on CRHM's future. While other rollups have stumbled lately, CRHM is continuing, in measured ways, to make acquisitions and integrate them. Recent conversations with management have increased our confidence in their pipeline and the ripple effect that their deals create in the GI community. We continue to like the physician services business and believe that increasing numbers of gastroenterology practices will outsource anesthesia services in order to focus on clinical outcomes, improve operating efficiency and strengthen financial performance." (3/27/2017)
Are investors shorting CRH Medical?
CRH Medical saw a increase in short interest in October. As of October 31st, there was short interest totalling 1,331,365 shares, an increase of 11.0% from the October 13th total of 1,198,901 shares. Based on an average trading volume of 93,628 shares, the short-interest ratio is currently 14.2 days. Currently, 1.9% of the shares of the stock are sold short.
Who are some of CRH Medical's key competitors?
Some companies that are related to CRH Medical include Sientra (SIEN), Palomar Medical Technologies (PMTI), T2 Biosystems (TTOO), Ocular Therapeutix (OCUL), SeaSpine Holdings Corporation (SPNE), Bioquell plc (BQE), Tandem Diabetes Care (TNDM), Surgical Innovations Group plc (SUN), Capnia (SLNO), Cytori Therapeutics (CYTX), Alliqua BioMedical (ALQA), Lombard Medical (EVARF), NeuroMetrix (NURO), InspireMD (NSPR), Great Basin Scientific (GBSN), Asante Solutions (PUMP), LDR Holding Corp (LDRH) and Symmetry Medical (SMA).
Who are CRH Medical's key executives?
CRH Medical's management team includes the folowing people:
- Anthony F. Holler M.D., Independent Chairman of the Board (Age 63)
- Edward J. Wright, Chief Executive Officer, Director
- Richard K. Bear, Chief Financial Officer (Age 48)
- Jay Kreger, President of CRH Anesthesia Management
- David Johnson, Independent Director
- Bergein F. Overholt M.D., Independent Director
- Todd R. Patrick, Independent Director (Age 48)
- Ian A. Webb, Independent Director (Age 61)
Who owns CRH Medical stock?
CRH Medical's stock is owned by a number of of retail and institutional investors. Top institutional investors include Mawer Investment Management Ltd. (8.05%), Stifel Financial Corp (2.25%), Canada Pension Plan Investment Board (0.00%), JPMorgan Chase & Co. (0.55%), TD Asset Management Inc. (0.15%) and AGF Investments Inc. (0.11%). View Institutional Ownership Trends for CRH Medical.
Who sold CRH Medical stock? Who is selling CRH Medical stock?
Who bought CRH Medical stock? Who is buying CRH Medical stock?
CRH Medical's stock was bought by a variety of institutional investors in the last quarter, including Mawer Investment Management Ltd., Canada Pension Plan Investment Board, JPMorgan Chase & Co., Stifel Financial Corp and TD Asset Management Inc.. View Insider Buying and Selling for CRH Medical.
How do I buy CRH Medical stock?
Shares of CRH Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CRH Medical's stock price today?
One share of CRH Medical stock can currently be purchased for approximately $1.80.
How big of a company is CRH Medical?
CRH Medical has a market capitalization of $140.84 million.
How can I contact CRH Medical?
CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.
MarketBeat Community Rating for CRH Medical (NYSEAMERICAN CRHM)MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for CRH Medical (NYSEAMERICAN:CRHM) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 3 Hold Ratings, 6 Buy Ratings, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 2.67)|
|Consensus Price Target: ||$7.83|
Consensus Price Target History for CRH Medical (NYSEAMERICAN:CRHM)
Analysts' Ratings History for CRH Medical (NYSEAMERICAN:CRHM)
(Data available from 11/22/2015 forward)
|11/17/2017||Morgan Stanley||Upgrade||Equal Weight -> Overweight|
|8/4/2017||Canaccord Genuity||Lower Price Target||Buy||$8.00 -> $5.00|
|8/4/2017||National Bank Financial||Upgrade||Sector Perform -> Outperform|
|7/24/2017||Scotiabank||Upgrade||Sector Perform -> Sector Outperform|
|7/21/2017||Royal Bank Of Canada||Upgrade||Sector Perform -> Outperform|
|7/18/2017||TD Securities||Downgrade||Buy -> Hold|
|7/14/2017||Bloom Burton||Downgrade||Buy -> Accumulate|
|7/17/2017||CIBC||Downgrade||Sector Outperform -> Sector Perform|
|3/27/2017||Cantor Fitzgerald||Reiterated Rating||Overweight||$8.00 -> $10.00|
Earnings History and Estimates Chart for CRH Medical (NYSEAMERICAN:CRHM)
Earnings History by Quarter for CRH Medical (NYSEAMERICAN CRHM)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/28/2018|| || || || || || || || |
|2/22/2017||12/31/2016||$0.04||$0.05||$23.30 million||$25.82 million||View||N/A|
Earnings Estimates for CRH Medical (NYSEAMERICAN:CRHM)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for CRH Medical (NYSEAMERICAN:CRHM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for CRH Medical (NYSEAMERICAN CRHM)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for CRH Medical (NYSEAMERICAN CRHM)
Financials are not available for this stock.
CRH Medical (NYSEAMERICAN CRHM) Chart for Wednesday, November, 22, 2017